Consolidated Statement Of Changes In Equity

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7324025

Concept 2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2023-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2023-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
Consolidated statement of changes in equity
Statement of changes in equity
Net assets
JPY
23,853,000,000 JPY
1,363,000,000 JPY
136,135,000,000 JPY
11,406,000,000 JPY
-28,613,000,000 JPY
129,433,000,000 JPY
7,184,000,000 JPY
7,184,000,000 JPY
7,184,000,000 JPY
11,462,000,000 JPY
1,413,000,000 JPY
128,506,000,000 JPY
118,627,000,000 JPY
11,462,000,000 JPY
9,000,000,000 JPY
-28,613,000,000 JPY
55,000,000 JPY
23,853,000,000 JPY
143,755,000,000 JPY
135,207,000,000 JPY
8,547,000,000 JPY
143,319,000,000 JPY
392,000,000 JPY
4,889,000,000 JPY
4,724,000,000 JPY
126,606,000,000 JPY
1,413,000,000 JPY
23,853,000,000 JPY
23,853,000,000 JPY
115,779,000,000 JPY
0 JPY
4,724,000,000 JPY
131,368,000,000 JPY
136,563,000,000 JPY
4,724,000,000 JPY
11,406,000,000 JPY
11,406,000,000 JPY
-30,026,000,000 JPY
-30,026,000,000 JPY
9,000,000,000 JPY
165,000,000 JPY
578,000,000 JPY
11,406,000,000 JPY
136,836,000,000 JPY
131,839,000,000 JPY
126,135,000,000 JPY
413,000,000 JPY
11,406,000,000 JPY
-28,714,000,000 JPY
433,000,000 JPY
125,492,000,000 JPY
4,551,000,000 JPY
4,551,000,000 JPY
4,551,000,000 JPY
11,406,000,000 JPY
1,413,000,000 JPY
136,590,000,000 JPY
126,347,000,000 JPY
114,645,000,000 JPY
11,406,000,000 JPY
9,000,000,000 JPY
-28,714,000,000 JPY
0 JPY
23,853,000,000 JPY
132,893,000,000 JPY
4,853,000,000 JPY
301,000,000 JPY
138,325,000,000 JPY
578,000,000 JPY
23,853,000,000 JPY
132,038,000,000 JPY
Changes during period
Dividends of surplus
-5,655,000,000 JPY
-5,655,000,000 JPY
-5,655,000,000 JPY
-5,655,000,000 JPY
-5,655,000,000 JPY
-5,655,000,000 JPY
-5,655,000,000 JPY
-5,652,000,000 JPY
-5,652,000,000 JPY
-5,652,000,000 JPY
-5,652,000,000 JPY
-5,652,000,000 JPY
-5,652,000,000 JPY
-5,652,000,000 JPY
Profit (loss) attributable to owners of parent
8,025,000,000 JPY
8,025,000,000 JPY
8,025,000,000 JPY
5,440,000,000 JPY
5,440,000,000 JPY
5,440,000,000 JPY
Disposal of treasury shares
1,470,000,000 JPY
1,470,000,000 JPY
1,470,000,000 JPY
55,000,000 JPY
1,415,000,000 JPY
55,000,000 JPY
1,470,000,000 JPY
1,415,000,000 JPY
55,000,000 JPY
27,000,000 JPY
27,000,000 JPY
27,000,000 JPY
27,000,000 JPY
27,000,000 JPY
27,000,000 JPY
Net changes in items other than shareholders' equity
-578,000,000 JPY
1,198,000,000 JPY
2,460,000,000 JPY
2,460,000,000 JPY
3,658,000,000 JPY
2,460,000,000 JPY
2,460,000,000 JPY
3,080,000,000 JPY
JPY
172,000,000 JPY
-136,000,000 JPY
172,000,000 JPY
35,000,000 JPY
172,000,000 JPY
35,000,000 JPY
172,000,000 JPY
Total changes during period
-578,000,000 JPY
2,847,000,000 JPY
3,838,000,000 JPY
JPY
JPY
JPY
1,198,000,000 JPY
JPY
4,296,000,000 JPY
JPY
6,756,000,000 JPY
55,000,000 JPY
1,413,000,000 JPY
2,460,000,000 JPY
3,658,000,000 JPY
2,460,000,000 JPY
2,827,000,000 JPY
2,460,000,000 JPY
2,370,000,000 JPY
55,000,000 JPY
6,918,000,000 JPY
1,413,000,000 JPY
55,000,000 JPY
-20,000,000 JPY
JPY
-20,000,000 JPY
JPY
JPY
1,133,000,000 JPY
-199,000,000 JPY
-1,524,000,000 JPY
JPY
JPY
-211,000,000 JPY
1,113,000,000 JPY
172,000,000 JPY
JPY
-136,000,000 JPY
-26,000,000 JPY
-1,489,000,000 JPY
JPY
172,000,000 JPY
JPY
35,000,000 JPY
172,000,000 JPY
-1,312,000,000 JPY
-1,312,000,000 JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.